98%
921
2 minutes
20
Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current assays identifying tumor-specific functional activation measure the upregulation of surface molecules, production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8 and CD4 tumor-specific reactive TILs , using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8 TILs can be detected compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4 and CD8 tumor-specific reactive TILs. , the combined detection of , , and identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire , which can be rapidly adopted in most cancer immunology laboratories.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543011 | PMC |
http://dx.doi.org/10.3389/fimmu.2021.705422 | DOI Listing |
J Control Release
September 2025
School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, Guangdong, China; Dongguan Liaobu Hospital, Dongguan 523400, Guangdong, China. Electronic address:
Fluorine-19 magnetic resonance imaging (F MRI) offers distinct advantages, including background-free signal detection, quantitative analysis, and deep tissue penetration. However, its application is currently limited by challenges associated with existing F MRI contrast agents, such as short transverse relaxation times (T), limited imaging sensitivity, and suboptimal biocompatibility. To overcome these limitations, a glutathione (GSH)-responsive triblock copolymer (PB7), featuring self-immolative characteristics, has been developed.
View Article and Find Full Text PDFCell Rep Med
September 2025
Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway. Electronic address:
Accurate identification of tumor-specific markers is vital for developing chimeric antigen receptor (CAR)-based therapies. While cell surface antigens are seldom cancer-restricted, their post-translational modifications (PTMs), particularly aberrant carbohydrate structures, offer attractive alternatives. Among these, the sialyl-Tn (STn) antigen stands out for its prevalent presence in various epithelial tumors.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Purpose: Glioblastoma (GBM) remains one of the most aggressive primary brain tumors with poor survival outcomes and a lack of approved therapies. A promising novel approach for GBM is the application of photodynamic therapy (PDT), a localized, light-activated treatment using tumor-selective photosensitizers. This narrative review describes the mechanisms, delivery systems, photosensitizers, and available evidence regarding the potential of PDT as a novel therapeutic approach for GBM.
View Article and Find Full Text PDFJ Colloid Interface Sci
September 2025
Institute of Biomedical Engineering, College of Medicine, Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, Chengdu 610031, PR China. Electronic address:
Pyroelectrodynamic therapy (PEDT) of tumors faces challenges due to its low electrocatalytic efficiency at mild temperature and the potential for off-target toxicity to healthy tissue. To overcome these issues, we have engineered pyroelectric nanoparticles (NPs) that feature a pH-triggered heterojunction structure and tumor-selective reactive oxidative species (ROS) production, faclitating synergistic PEDT and mild photothermal therapy (PTT). Herein, molybdenum trioxide (MoO) was deposited in-situ on the surface of tetragonal BaTiO (tBT) to create tBT@MO.
View Article and Find Full Text PDFJ Colloid Interface Sci
August 2025
Public experimental research center of Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; The school of pharmacy of Xuzhou Medical University, Xuzhou, Jiangsu 221004, China. Electronic address:
Manganese dioxide (MnO) nanomaterials have emerged as a promising class of nanoplatform for the therapeutic management of tumors due to their regulable physicochemical properties and good biocompatibility. However, the rational design of MnO nanomaterials often decreased the therapeutic efficacy of tumors due to the inherent protective mechanisms of eliminating the imbalance of Mn in cells. Herein, we firstly prepared a novel Zn ion doped MnO nanoplate (Zn-MnO) employing different zeolitic imidazolate framework 8 (ZIF8) precursors as Zn ion source, which possessed enhanced T1-weighted magnetic resonance imaging (MRI) signal, reactive oxygen species (ROS) generation capacity and efficient photothermal conversion.
View Article and Find Full Text PDF